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Abstract
Background: Ectodysplasin-A appears to be a critical component of branching morphogenesis.
Mutations in mouse Eda or human EDA are associated with absent or hypoplastic sweat glands,
sebaceous glands, lacrimal glands, salivary glands (SMGs), mammary glands and/or nipples, and
mucous glands of the bronchial, esophageal and colonic mucosa. In this study, we utilized EdaTa
(Tabby) mutant mice to investigate how a marked reduction in functional Eda propagates with time
through a defined genetic subcircuit and to test the proposition that canonical NFκB signaling is
sufficient to account for the differential expression of developmentally regulated genes in the
context of Eda polymorphism.
Results: The quantitative systems analyses do not support the stated hypothesis. For most NFκB-
regulated genes, the observed time course of gene expression is nearly unchanged in Tabby (EdaTa)
as compared to wildtype mice, as is NFκB itself. Importantly, a subset of genes is dramatically
differentially expressed in Tabby (Edar, Fgf8, Shh, Egf, Tgfa, Egfr), strongly suggesting the existence
of an alternative Eda-mediated transcriptional pathway pivotal for SMG ontogeny. Experimental and
in silico investigations have identified C/EBPα as a promising candidate.
Conclusion: In Tabby SMGs, upregulation of the Egf/Tgfα/Egfr pathway appears to mitigate the
potentially severe abnormal phenotype predicted by the downregulation of Fgf8 and Shh. Others
have suggested that the buffering of the phenotypic outcome that is coincident with variant Eda
signaling could be a common mechanism that permits viable and diverse phenotypes, normal and
abnormal. Our results support this proposition. Further, if branching epithelia use variations of a
canonical developmental program, our results are likely applicable to understanding the phenotypes
of other branching organs affected by Eda (EDA) mutation.
Background
Branching morphogenesis is a common mechanism of
mammalian development (salivary glands, lungs, mam-
mary glands, pancreas, kidney, etc.), and has been a classic
topic of study for generations of developmental biologists
[1]. Based on recent findings regarding signal transduc-
tion pathways and transcriptional control, it has reasona-
bly been proposed that all branching systems use
variations of a canonical developmental program [2].
Ectodysplasin-A, a protein required for epithelial differen-
tiation, appears to be an important constituent of such a
program.
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Ectodysplasin-A (Eda  in mouse, EDA  in human) is
mapped to the X-chromosome [3,4]. Eda is a glycosylated,
oligomeric type II membrane protein with three collagen-
ous repeat domains and a TNF homology domain [3-6].
Eda is shed from the cell membrane and binds as a trimer
to its trimerized cognate receptor (Edar) [7,8]. Like TNF/
TNFR signaling, Eda/Edar signaling is thought to be pri-
marily through the canonical NFκB pathway [9-13]. The
initial appearance of Eda and Edar proteins in Late Pseu-
doglandular/Canalicular Stage (E15) submandibular sali-
vary glands (SMGs) in vivo indicate that they participate in
late branching morphogenesis and histodifferentiation
[14]. In vitro study of the Eda/Edar pathway in embryonic
SMG development indicates that this pathway is impor-
tant for epithelial cell proliferation, lumina formation,
and histodifferentiation; exogenous Eda delivered to SMG
explants upregulate NFκB activation and nuclear localiza-
tion [14].
Mutations in mouse Eda or its human homologue EDA
result in hypohydrotic ectodermal dysplasia (HED), a syn-
drome variably characterized by absent or hypoplastic
teeth, hair, sweat glands, sebaceous glands, lacrimal
glands, salivary glands, mammary glands and/or nipples,
and mucous glands of the bronchial, esophageal and
colonic mucosa [14-22].
The mouse EdaTa (Tabby) allele is characterized by a ~2 kb
deletion [3,4]. Specifically, genomic DNA hybridized with
an exon 1 probe shows a deletion including the coding
region, and primers for DNA flanking exon 1 fail to
amplify in a PCR assay (Jackson Laboratories; http://
www.informatics.jax.org). Importantly, RT-PCR assays of
embryonic EdaTa (Tabby) skin reveals that EdaTa transcript
levels are about 10–20% of that seen in the wildtype
[23,24]. This may reflect the fact that DNA sequences that
regulate gene transcription occupy no fixed position rela-
tive to coding DNA regions and are often diffuse and
widely dispersed, including secondary ("shadow")
enhancers [25,26]. Secondary enhancers map far from the
target gene and mediate activities overlapping the primary
enhancer, accounting for why deletions of well-defined
enhancers are sometimes associated with weak or no phe-
notypic abnormality [25].
In this study, we utilized EdaTa (Tabby) mutant mice to
investigate the in vivo relationship between Eda/Edar sign-
aling and progressive (E13-NB) SMG morphogenesis and
histodifferentiation. Our investigation reveals that, from
the outset (E13), embryonic Tabby SMGs are smaller,
exhibit fewer branches, and are developmentally delayed
compared to wildtype (WT) glands. By E18, Tabby glands
remain smaller with fewer presumptive acini than WT,
though both display a similar degree of terminal differen-
tiation (presumptive functional maturation), as evi-
denced by mucin (MucCAM/Muc10) protein expression.
The key question is how altered Eda function is related to
abnormal SMG ontogeny.
Developmental biology has progressed from studying one
or two molecules at a time to studying scores of mole-
cules. Such studies require complex experiments and
mathematical analyses of their results. While the preferred
approach for data analysis has been statistical, its value is
limited for mechanistic understanding of signal transduc-
tion, mostly because the approach is correlational. To
understand how a specific ligand/receptor binding (or
lack thereof) produces a change in cell/tissue behavior,
one is compelled to utilize a dynamic model of a larger
relevant genetic subcircuit. Such dynamic models allow
one to test different sets of unbiased assumptions and
determine if the predicted behavior matches the actual.
Thus, the wider goal of the present study was to under-
stand how a marked reduction in functional Eda propa-
gates with time through a defined subcircuit that includes
5 signaling pathways that are both critical for SMG ontog-
eny and share post-activation downstream targets. More
specifically, it was the central objective of our extensive
quantitative  study to demonstrate the way in which a
mechanistic pathway diagram can be programmatically
transformed to a corresponding system of ordinary differ-
ential equations in order to quantitatively test the propo-
sition that the canonical NFκB signaling cascade is
sufficient to account for the differential quantitative
expression of developmentally-regulated genes in the con-
text of Eda polymorphism (Eda v. EdaTa).
Quantitative gene expression analysis and mechanistic
kinetic modeling reveal that the EdaTa allele is associated
with significantly downregulated Edar,  Shh  and  Fgf8
expression, and vastly upregulated Egf/Tgfα/Egfr expres-
sion. Further, the results revealed that Eda/Edar signaling
is not a major determinant of NFκB signaling in normal
and mutant Tabby SMG development; rather, TNF is.
Moreover, the evidence strongly points to the existence of
an important, alternative Eda-initiated transcriptional
control pivotal to SMG development. These results are
likely to be applicable to other branching organs affected
by Eda (EDA) mutation.
Results
The SMG in the adult Tabby mouse is smaller than the
wildtype (WT) gland and is characterized by decreased
granular convoluted ducts and acini; there is a significant
decrease in mucin protein in the hypoplastic Tabby SMGs
compared to WT, but not more than expected given the
gland size differences [14,15]. To elucidate the natural his-
tory of the pathogenesis, we compared the developmental
phenotypes of embryonic (E) days 13–18 Tabby and WTBMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
Page 3 of 22
(page number not for citation purposes)
SMGs and relate these to multiple gene expression and
putative functional integration of related pathways.
Progressive pathogenesis of Tabby SMGs
From the outset, embryonic Tabby SMGs are smaller,
exhibit fewer branches and are developmentally delayed
compared to WT glands (Fig. 1). At E13, the Tabby gland
is characterized by a solid epithelial stalk ending in a bulb
and achieving the Initial Bud stage (Fig. 1A), whereas the
WT gland exhibits deep clefts and the formation of 3–6
epithelial buds (branches) (i.e. Late Initial Bud stage) (Fig.
1B). Moreover, although the Pseudoglandular stage, com-
posed of a network of epithelial branches and terminal
buds, is achieved in E14 WT SMGs (Fig. 1D), the Tabby
gland has only progressed to Late Initial Bud stage on E14
(Fig. 1C) and does not achieve the Pseudoglandular stage
until E15 (Fig. 1E). This developmental delay of approxi-
mately 1 day persists in Tabby glands, with the Canalicular
stage being seen in E15 WT and E16 Tabby glands (com-
pare Fig. 1F to 1G) and the Early Terminal Bud stage being
seen in E16 WT and E17 Tabby glands (compare Fig. 1H
to 1I, 2A to 2B). The initial detection of immunolocalized
mucin protein in Tabby E17 glands, as well as the similar-
ity of its distribution pattern to E16 WT glands, indicates
that Tabby proacinar maturation is also delayed, but not
precluded (compare Fig. 2A to 2B). At E18, the Tabby
glands remain smaller and exhibit fewer presumptive
acini than E18 WT glands (compare Fig. 1K to 1L), a hypo-
plastic phenotype. Nevertheless, both E18 WT and Tabby
SMGs display distinct proacinar lumina bounded by a sin-
gle layer of cuboidal epithelium and filled with mucin
protein, as well as continuity between ductal and proaci-
nar lumina (compare Fig. 1K to 1L, and 2C to 2D). This
similarity in E18 Tabby and WT phenotypes indicates that
terminal differentiation (presumptive functional matura-
tion) is less affected by the EdaTa mutation.
Gene expression
A key principle of signaling and transcriptional regulation
of development is that a wide array of ontogenic effects
can emerge from a relatively small number of individual
molecular components [27]. This nonlinear process is
dependent on the functional integration of information
transmitted by diverse pathways. Many such pathways in
SMG ontogeny have been identified (see reviews, [28-
31]). The putative functional relationships within and
between pathways have been modeled for mouse SMGs as
the estimative equivalent of a "café napkin" sketch,
namely a diagrammatic genetic network [28,32].
Mapping genes to their function is called the "genotype-
to-phenotype problem," where phenotype is whatever is
changed in the organism when a gene's function is altered
[33]. Because developmental regulation is both robust
and degenerate, it is limiting to simply investigate the
average effects of single network genes across samples,
large or small [34]. Rather, we are compelled to map gen-
otype to phenotype within the context of the underlying
complexity of the networks that regulate cellular functions
[33].
Here we investigated a subcircuit (Fig. 3) that includes 31
probative genes (Tables 1, 2 and 3) in 5 signaling path-
ways that are both critical to SMG ontogeny and share
post-activation downstream targets: Eda, Tnf, Il6, Egf, Fgf
[14,28-31,35-42]. This approach has proven very useful,
not least because it is experimentally constrained and
computationally accessible [43]. Below we present novel
emergent properties that would not be otherwise evident.
WT gene expression
We determined the sequential time-dependent changes in
the expression of 31 genes from the earliest time of immu-
nodetectable Eda and Edar to newborn by quantitative
RT-PCR. The presentation of wildtype (WT) gene expres-
sion data for embryonic day 16 (E16) to newborn (NB) is
found in Table 1. The relative expression ratio (R) is the
mean increase or decrease in gene expression in WT
glands compared to a single standard, WT E15 glands, the
earliest time of Eda and Edar protein expression. These
data are particularly heuristic in our attempt to more fully
expand upon what is already known about the control of
embryonic SMG branching from prior genotype to pheno-
type analyses [14,28,30-32,37,38,41,42,44].
Normal Terminal Bud Stage (E16-NB) maturation is criti-
cal to subsequent acini and ductal terminal differentia-
tion, postnatally. The steady state gene expression of Fgf8
and Fgfr2, and the more dramatic 20+ fold upregulation
of Fgf10, suggests that the Fgf pathways are important to
Terminal Bud Stage maturation in the same way they are
prior to this stage. This also may be said of the function-
ally related Shh  gene expression. Progression from the
Pseudoglandular Stage to the Canalicular Stage, and contin-
ued epithelial branching, also includes Eda/Edar, Tnf and
Il6 signaling through the canonical NFκB pathway. The
importance of these pathways for Terminal Bud Stage mat-
uration appears considerably diminished: Eda, Edar, Edar-
add, Tnf, Il6, and Nfkb1 gene expression are significantly
(P < 0.01) downregulated. Finally, the Egf/Tgfα/Egfr path-
way regulates the rate of branching and histodifferentia-
tion in preparation for progression from the Canalicular
Stage to the Terminal Bud Stage. The steady state of Egf
expression and the significant upregulation of Tgfα and
Egfr  suggest the importance of this signaling pathways
through Early Terminal Bud Stage (E16); however, beyond
this point there is a highly significant (P < 0.01) decline in
Egf, Tgfα, and Egfr expression, suggesting a greatly dimin-
ished role in SMG maturation.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Embryonic Tabby SMGs are developmentally-delayed Figure 1
Embryonic Tabby SMGs are developmentally-delayed. E13 Tabby (TA) SMG (A) has achieved the Initial Bud stage, con-
sisting of a single end bulb. In contrast, E13 wildtype (WT) glands (B) are characterized by cleft formation in the end bud and 
the formation of a few branches, indicating that it has achieved the Late Initial Bud Stage. The Pseudoglandular stage, composed of 
a network of epithelial branches and end buds (b), is seen in E14 WT (D) and E15 Tabby (E) SMGs. The presence of ductal 
lumina (arrows) indicates that the E15 WT (F) and E16 Tabby (G) SMGs have achieved the Canalicular stage. The presence of 
distinct lumina surrounded by cuboidal epithelia (black arrowhead) in some, but not all, terminal end buds indicates that E16 
WT (H) and E17 Tabby (I) SMGs have achieved the Early Terminal Bud stage. By E18, differences in branching morphogenesis 
and glandular maturation are seen between E18 WT (L) and Tabby (K) glands. Note that the E18 Tabby glands (K) are smaller 
and exhibits fewer branches than E18 WT glands (L); its branching morphogenesis appears similar to that seen in E17 WT (J) 
glands. However, the observation of distinct proacinar lumina surrounded by a single layer of cuboidal epithelium (blue arrow-
head) and continuity between ductal and proacinar lumina in both E18 Tabby (K) and WT (L) glands (i.e. Late Terminal Bud 
stage) indicates the similarity in E18 Tabby and WT maturation. Bar: A-D, 40 μm; E-L, 30 μm.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Tabby gene expression
To determine if the sequential expression of these impor-
tant 31 genes differs in Tabby SMGs from that seen in WT
SMGs, we also compared Tabby E16 to NB to the same
standard (WT E15). The presentation of Tabby SMG gene
expression data for E16 to NB, and its comparison to WT
is found in Tables 2 and 3. It is readily apparent that
embryonic EdaTa SMGs have many highly significant (P <
0.01) gene expression differences as compared to WT.
Such differences have always to be viewed in the context
of progressive SMG pathogenesis (Figs. 1, 2).
Though Eda gene expression in embryonic EdaTa SMGs are
3–19% that of WT, in the Early Terminal Bud Stage there is
a 4-fold increase in Nfkb1 gene expression relative to WT
(Table 3). This may largely be explained by the concomi-
tant 11-fold increase in Tnf expression, Tnf being a power-
ful inducer of NFκB activation in SMGs [41]. By Mid to
Late Terminal Bud stage, this response is replaced by near
normal Nfkb1 and Tnf expression (Table 3), and dramati-
cally upregulated Egf/Tgfα/Egfr expression: Egf by a rela-
tive 10–100 fold; Tgfα by a relative 10–30 fold, Egfr by a
relative 2.5–5 fold (Table 3). This unexpected upregula-
tion of Egf/Tgfα/Egfr message is reflected in the expression
of immunodetectable proteins (Fig. 4), with a substantial
increase in Egf, Tgfα, and Egfr proteins being seen in
Tabby SMGs as compared to WT glands. At the same time,
diminished Eda expression is associated with significantly
(P < 0.01) downregulated Shh and Fgf8 expression, an
outcome previously shown to be correlated with severe
SMG pathology [38,44]. Shh and Fgf8 are known to posi-
tively and reciprocally regulate one another in SMGs [38].
Still, while Shh and Fgf8 expression in WT SMGs is highly
correlated (P < 0.01) and the variation of one accounts for
nearly all of the variation in the other, in EdaTa SMGs they
are not at all correlated (P > 0.90), one accounting for less
than 4% of the variation in the other.
In summary, then, the pathology of EdaTa SMGs, relative
to the circumscribed signaling subcircuit (Fig. 3), is asso-
ciated with downregulated Shh and Fgf8 gene expression.
Perhaps, as a mark of this subcircuit's robustness, the
potential severity of the SMG pathology may be mitigated
by vastly upregulated Egf/Tgfα/Egfr gene expression (Table
3) and protein expression (Fig. 4). These results naturally
raise questions regarding the underlying mechanism that
links the loss-of-function EdaTa mutation to the positive
and negative regulation of the 5 genes just noted (Shh,
Fgf8, Egf, Tgfα, Egfr), and the overall putative relationship
to NFκB-mediated gene regulation.
Network analysis
The expression of an individual gene in a developing
organ is not a soliloquy; rather, it acts in a chorus of quan-
titative functional relations appropriately termed a genetic
circuit, network or connections map. It is the task of sys-
tems biology to quantitatively define and analyze the
parts (subcircuits) of the whole, the goal being to put it all
together in the future [45-49]. To do this, two effective
strategies have emerged. One seeks to infer biologic path-
ways from large data sets and increasingly powerful soft-
ware tools for managing and searching literature and
pathway databases [50]. The second seeks to construct
and test increasingly complex mechanistic models of bio-
logic systems [51]. Here we have combined these strate-
gies to determine the way in which a mechanistic pathway
diagram (derived from our prior studies, the literature,
and pathway databases) can be programmatically trans-
formed to a corresponding system of ordinary differential
equations in order to quantitatively test the proposition
that the canonical NFκB signaling cascade is sufficient to
account for the differential quantitative expression of
developmentally regulated genes in the context of Eda
polymorphism (Eda v. EdaTa).
Pathway and literature databases were mined for proc-
esses that interrelate a quantitatively measured panel of
genes which are critical to SMG development (Tables 1, 2
and 3; Fig. 3). Mined processes were assembled into a
mechanistic kinetic framework and the model was tested
for consistency with the WT and Tabby quantitative RT-
PCR derived expression data. The resulting best-fit mech-
anistic system diagram contains 138 states (a state being a
molecule or a complex in a physical place) in 5 cellular
locations (nucleus, cytoplasm, secretory pathway, plasma
membrane and extracellular space), and 217 processes
(transport, chemical transformation or binding). The sys-
tem diagram is too large to be displayed legibly on a jour-
nal page, but is provided as a scalable PDF file in
Additional file 1, along with access to all the equations
and parameters for both WT and Tabby data sets, as well
as the fits of the quantitative experimental data (see Addi-
tional file 2; Additional file 3; Additional file 4; Additional
file 5).
Previous systems analyses have utilized computational
methods that allow ready deduction of genetic network
connectivity and functional properties solely from gene
expression data, temporal or not [52]. Still, recent studies
in yeast and E. coli compel the caveat that the ratios of
protein levels between mutant and WT may not have a
one-to-one correlation with those of the corresponding
mRNAs [53,54]. Further, since the mechanistic diagram
inevitably includes a large number of proteins as well as
expressed mRNAs, we concede at the outset that gene
expression data alone are not sufficient to allow highly
detailed parameter identification of the downstream pro-
tein networks.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Fortunately, the kinetic characteristics of signaling circuits
provide general constraints that support quantitative anal-
ysis of gene expression data in isolation. First, it is gener-
ally agreed that protein transport from the site of synthesis
in the ER to the cell surface requires no more than 30 min-
utes [55]. Second, it is widely acknowledged that signaling
pathways require on the order of only two minutes to con-
vey information from the plasma membrane to the
nucleus. Since the developmental time courses we analyze
include transients on a time scale of 4 to 5 days, we
adopted the working hypothesis that signal transduction
events (mediated by protein transport in the secretory
pathway, receptor binding, and binding to response ele-
ments) are fast relative to the dynamics of transcription,
mRNA turnover, translation and protein turnover. This
simplification allows a full mechanistic test of a complex
hypothetical model even in the absence of experimental
protein kinetic data on secreted cytokines and growth fac-
tors, activated enzymes, and transcription factors (see
Methods).
It is readily apparent that Eda is not a major determinant
of NFκB signaling. This conclusion is inescapable given
the large number of genes in the model (Fig. 3; see Addi-
tional file 1) whose transcription is reported to be signifi-
cantly regulated by canonical NFκB. Given our working
assumption that all differences between WT and Tabby
developmental mRNA profiles are secondary to differen-
tial Eda expression, it must follow that if Eda is the domi-
nant determinant of Eda/Edar signaling, then the Tabby
state of many-fold less Eda must propagate in this kinetic
model (see Additional file 1) into much reduced expres-
sion of genes whose transcription is significantly regulated
by NFκB. To the contrary, only 4 (Edar, Fgf8, Shh, Egf) of
the 17 genes thought to be NFκB response genes (Fig. 3)
have dramatically different time courses in WT and Tabby
SMGs (Fig. 5; see Additional file 2). This strongly suggests
that Eda is not a major determinant of NFκB activation in
SMG branching morphogenesis, and presages the exist-
ence of an additional Eda-initiated transcriptional control
of the 4 genes: Edar, Fgf8, Shh, Egf.
Concomitantly, it is informative to consider Nfkb1 gene
expression itself. The mechanistic model (see Additional
file 1) accounts for the observed significant, but transient,
decrease in WT and Tabby SMGs (Tables 1 and 2); Nfkb1
expression has essentially the same time course in WT and
Tabby SMGs (Fig. 6). Interestingly, the mechanistic model
(see Additional file 1; Additional file 3; Additional file 4;
Additional file 5) demonstrates that the resulting decrease
in protein synthesis is largely buffered by the pre-existing
cytoplasmic pool of NFκB1, and thus the downregulation
of Nfkb1 has little effect on the propagation of Eda, Fgf10,
and Tnf induced signals to the nucleus. Further, since
prior SMG studies demonstrated that a significant portion
of the activation and nuclear translocation of NFκB can be
accounted for by the variation in Tnf signaling [32], we
tested and corroborated the hypothesis that Tnf, not Eda,
is the dominant controller of IKK activation in developing
WT and Tabby SMGs (see Additional file 1; Additional file
3; Additional file 4; Additional file 5).
To address this question further, we employed an in vitro
loss-of-function strategy to determine if loss of canonical
NFκB function abrogates Eda-enhanced SMG branching
and maturation. We utilized SN50, a cell permeable
inhibitor of NFκB translocation into the nucleus [56], at a
concentration (100 μg/ml) previously shown to entirely
preclude Tnf- and Eda-induced NFκB nuclear transloca-
tion and to significantly inhibit embryonic SMG branch-
ing ([32,57], unpublished). To enhance SMG branching,
we used 250 ng/ml Eda-A1 in a manner previously
reported [14]. Thus, E14 explants were cultured for 7 days
(E14 + 7) in the presence of 250 ng/ml Eda-A1, 100 μg/ml
SN50, or 250 ng/ml Eda-A1 + 100 μg/ml SN50; controls
consisted of E14 explants cultured in control medium
alone.
Mucin protein expression in Tabby and WT glands Figure 2
Mucin protein expression in Tabby and WT glands. 
Mucin protein is immunolocalized in some, but not all, termi-
nal end buds in E17 Tabby (A) and E16 WT (B) SMGs (Early 
Terminal Bud stage). By E18, although E18 Tabby SMGs (C) 
display a notable reduction in total proacini displaying mucin 
protein compared to E18 WT glands (D), the observation of 
mucin protein in all proacinar lumen in both E18 Tabby and 
WT glands indicates similar glandular differentiation and that 
both glands have achieved the Late Terminal Bud stage. Bar, 20 
μm.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Eda supplementation induces a substantial increase (Jas-
koll et al., 2003; data not shown) and SN50 induces a
marked decrease (compare Fig. 7C, D to 7A, B) in embry-
onic SMG branching morphogenesis and terminal differ-
entiation, as indicated by mucin protein expression. The
presence of exogenous Eda supplementation in SN50-
treated explants "rescued" the SN50-induced abnormal
phenotype and restored it toward that seen in controls
(compare Fig. 7E, F to 7A, B). Note that Eda + SN50-
treated glands exhibit a marked increase in epithelial ter-
minal buds, lumina formation, and immunodetectable
mucin protein compared to glands treated with SN50
Subcircuit Map: A relational model that postulates how signaling events likely propagate during SMG development; a concep- tionally simple subcircuit for subsequent kinetic modeling (see Additional file 1 and text) that is experimentally constrained and  computationally accessible Figure 3
Subcircuit Map: A relational model that postulates how signaling events likely propagate during SMG develop-
ment; a conceptionally simple subcircuit for subsequent kinetic modeling (see Additional file 1and text) that is 
experimentally constrained and computationally accessible. This subcircuit is composed of 5 signaling pathways that 
are both critical to SMG ontogeny and share post-activation downstream targets.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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alone (compare Fig. 7E, F to 7C, D). Taken together, our
results would indicate that a fully functional NFκB path-
way is not the sine qua non for Eda signaling, and that Eda
signaling likely uses additional, more critical and yet uni-
dentified, pathway(s).
These conclusions were supported by gene expression
analysis (Fig. 8). SN50-treated explants show a decline in
gene expression of 9 of 10 NFκB1 response genes (Fig.
8A). An optimized (neural network) gene expression
model was derived, resulting in a molecular signature that
was able to distinguish between SN50-treated and Eda-
treated explants with 100% sensitivity and specificity (Fig.
8B). More importantly, when we used the derived model
to classify the gene expression data of Eda + SN50-treated
explants, we found that all Eda + SN50-treated explants (n
= 9) were classified as "Eda-treated" and none were classi-
fied as "SN50-treated." This is consistent with the histo-
logic "rescue" (Fig. 7E) and again suggests Eda signaling
uses pathways in addition to NFκB.
Within our gene expression datasets (Tables 1, 2 and 3),
there are four growth factors and two growth factor recep-
tors whose quantitative expression time courses are dra-
matically different in Tabby SMGs relative to WT: Egf,
Tgfα, Shh, Fgf8, Edar, Egfr (Figs. 5, 9). The mechanistic
model (see Additional file 1; Additional file 3; Additional
file 4; Additional file 5) is internally consistent with some
of these but totally incapable of accounting for others. For
Shh  and  Fgf8, the small differences in nuclear NFκB1
caused by differential Tnf signaling plus the purported
feedback of these genes on one another are sufficient to
explain the temporal phenotypes of Tabby gene expres-
sion reasonably well. For Egf and Edar, the necessity for a
second (non-NFκB) Eda-induced transcriptional regula-
tor is clearly indicated by the discrepancies between
model solution and mRNA expression data. For Tgfα and
Egfr, the model solutions are internally consistent but the
link to Eda remains unknown. That is, the model can cor-
rectly propagate the different temporal phenotypes of WT
Table 1: Relative Gene Expression (R)*: Wildtype (WT)
Gene E16 E17 E18 E19 NB
Eda 0.32 0.27 0.49 0.74 0.67
Edar 0.18 0.10 0.23 0.45 0.67
Edaradd 1.00 0.54 0.58 0.52 0.54
Tnf 0.09 0.07 0.06 4.98 1.00
Traf2 1.00 1.00 1.00 1.34 1.00
Traf6 0.74 1.00 1.00 1.45 1.00
Nfkb1 0.25 0.17 0.34 1.00 1.00
Nfkb2 1.00 1.00 1.00 1.00 2.28
Rela 2.28 1.99 2.34 3.64 1.00
Relb 0.54 0.47 0.24 1.00 1.00
Ikkalpha 1.00 1.00 1.00 1.00 1.00
Ikkbetta 1.00 1.00 1.00 1.00 1.00
Ikbalpha 1.00 1.44 1.00 2.81 3.28
Il6 0.46 0.15 0.26 0.24 1.00
Shh 0.32 1.00 1.00 1.00 1.00
Fgf8 0.25 1.00 1.00 1.00 1.00
Fgf10 29.01 23.84 25.29 0.24 1.00
Fgfr2 1.00 1.00 1.00 1.00 1.00
Egf 1.00 0.10 0.08 0.02 0.01
Tgfalpha 2.60 0.34 0.37 0.18 0.22
Egfr 1.47 0.61 0.66 0.40 0.43
Erk1 1.00 1.00 1.00 2.42 1.00
Erk2 0.65 1.00 1.00 1.00 0.52
c-myc 0.51 0.57 0.47 1.00 0.61
Cyclind1 1.00 0.67 1.00 0.51 0.33
Cdk1 1.00 0.57 1.00 0.42 0.24
Pi3K 0.82 1.00 0.86 1.00 1.00
Akt 1.00 1.00 1.00 1.00 1.00
P53 0.80 1.00 0.49 0.51 0.28
Casp3 1.00 1.00 1.00 1.00 0.53
Stat3 1.00 1.00 1.00 1.88 1.00
* R = Σr/n, where gene expression (R) is "normalized" to WT-E15 (r 
= WT-E16/WT-E15, r = WT-E17/WT-E15, etc.), and n ≥ 9. Thus, 
entries in each cell are mean values (R); values greater or lesser than 
1 are significant at P < 0.01 or less.
Table 2: Relative Gene Expression (R)*: Tabby (Ta)
Gene E16 E17 E18 E19 NB
Eda 0.06 0.04 0.02 0.07 0.02
Edar 0.38 0.03 0.02 0.36 0.14
Edaradd 0.76 0.61 0.36 0.33 0.31
Tnf 1.00 0.08 0.02 3.90 1.00
Traf2 1.00 1.00 1.00 1.00 1.00
Traf6 1.00 1.24 1.00 1.00 1.69
Nfkb1 1.00 0.13 0.21 1.00 1.13
Nfkb2 0.61 1.00 1.00 1.00 1.72
Rela 1.00 1.00 2.06 2.03 2.79
Relb 0.26 0.29 0.16 0.48 1.00
Ikkalpha 1.00 1.00 1.00 2.04 1.00
Ikkbetta 1.00 1.00 1.00 3.89 1.00
Ikbalpha 1.00 1.00 1.45 1.00 3.13
Il6 1.00 0.33 0.11 0.27 0.17
Shh 0.19 0.42 0.23 0.24 0.48
Fgf8 0.19 0.28 0.40 0.27 0.22
Fgf10 7.40 19.54 26.51 0.25 0.17
Fgfr2 1.00 0.83 0.83 1.00 1.00
Egf 1.00 1.00 1.00 1.00 1.00
Tgfalpha 1.00 3.59 4.74 4.20 6.07
Egfr 0.77 1.52 1.73 1.48 2.31
Erk1 1.00 1.00 2.14 1.00 2.24
Erk2 1.00 1.00 1.00 0.64 1.00
c-myc 1.00 0.59 0.57 0.37 1.00
Cyclind1 1.00 0.79 0.65 0.42 0.51
Cdk1 1.00 1.00 0.46 0.47 0.23
Pi3K 1.00 1.00 0.76 0.68 0.83
Akt 1.00 1.00 1.00 1.00 1.00
P53 0.56 0.64 0.43 0.36 0.48
Casp3 1.00 0.52 0.55 1.00 0.55
Stat3 1.00 1.00 1.40 1.00 2.01
* R = Σr/n, where gene expression (R) is "normalized" to WT-E15 (r 
= Ta-E16/WT-E15, r = Ta-E17/WT-E15, etc.), and n ≥ 9. Thus, entries 
in each cell are mean values (R); values greater or lesser than 1 are 
significant at P < 0.01 or less.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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and Tabby gene expression, but the model cannot explain
the causal chain of events that links these genes to Eda.
These discrepancies and missing links compelled us to
consider an alternative mechanistic explanation and
refine the model.
To wit, we hypothesized and tested the alternative model
that a second pathway is activated by Eda/Edar signaling,
and that its activated transcription factor ("TFx") regulates
the six differently expressed genes in unique ways (Fig.
10). With this addition, all six quantitative gene expres-
sion time courses are now internally consistent with and
accounted for by the mechanistic model. Further, it is pos-
sible to deduce whether the added transcriptional regula-
tion is positive or negative. If gene expression is decreased
in Tabby SMGs, TFx must be a positive regulator of that
gene. Conversely, if gene expression is increased in Tabby
SMGs, then TFx must be a negative regulator of transcrip-
tion. Examination of the quantitative gene expression
data (Tables 1 and 2) reveals that there are three of each:
Edar, Shh and Fgf8 are positively regulated by the Eda-acti-
vated TFx; Egf, Tgfα, and Egfr are negatively regulated (Fig.
10). The identity of TFx is presently uncertain. However,
further in silico, in vivo and in vitro investigations suggest a
promising candidate.
Searching for TFx
Regulatory trans-acting transcription factors (TF) activate
or repress transcription by physical interaction with
genomic cis-regulating DNA elements that may be found
in promoters or at some distance from the target gene's
start site(s) (see review, [58]). Putative interactions
between TFs and their target DNA sequences can be iden-
tified by web-based tools for searching TF binding sites in
DNA sequences. Using AliBaba 2.1, TRANSFAC 12.1,
MATCH 11.2, and P-MATCH 1.0 (see Methods), we deter-
mined that the most probable identity of TFx is CCAAT/
enhancer binding protein alpha (C/EBPα). C/EBPα is part
of a family of leucine zipper proteins that control the dif-
ferentiation of many cell types, as well as regulate cell pro-
liferation [59]. Gene and protein analyses are consistent
with our in silico result and model prediction (Fig. 10).
Quantitative RT-PCR reveals a 60% decline in Cebpa mes-
sage in Tabby glands relative to WT at E16, and a 25%
decline at E17. In addition, there is a dramatic reduction
in activated, nuclear-localized C/EBPα protein in Tabby
SMGs relative to WT SMGs at E17 (compare Fig. 11B to
11A). To further delineate the relationship between Eda/
Edar signaling and C/EBPα, we compared the spatial dis-
tribution of C/EBPα protein in Eda-treated and control
E14 + 7 explants (compare Fig. 11D to 11C). Enhanced
Eda/Edar signaling in vitro induces a notable increase in
activated, nuclear-localized C/EBPα protein. Taken
together, our in vivo and in vitro data suggest that C/EBPα
is an Eda responsive gene, thus a promising TFx candidate.
The ability of C/EBPα to regulate differentiation and pro-
liferation in a context-specific manner often depends on
the presence of specific collaborating TFs [59,60]. Com-
posite cis-regulating elements are combinations of two or
more TF binding sites with synergistic regulatory action
[61]. Our model predicts that 4 key genes (Shh, Fgf8, Edar,
Egf) would contain NFκB/C/EBPα composite elements
(Fig. 10). Scanning all known human 5'-flanking
sequences, Shelest et al. [61] found that the most abun-
dant composite elements were of the NFκB/C/EBPα type,
including one in the Egf  sequence and another in the
sequence of a TNF receptor superfamily member. Apply-
ing the model for composite elements of the NFκB/C/
EBPα type [61], we determined that such putative com-
posite elements were also present in the murine sequences
of Shh, Fgf8, Edar, and Egf.
That C/EBPα is the identity of postulated TFx in the model
(Fig. 10) is far from certain. Still, it is an informed hypoth-
esis which can be tested further with protein-protein and
protein-DNA interaction assays of high sensitivity and
specificity, among other strategies.
Table 3: Relative Gene Expression: Ta/WT
Gene E16 E17 E18 E19 NB
Eda 0.19 0.15 0.04 0.09 0.03
Edar 2.11 0.30 0.09 0.80 0.21
Edaradd 0.76 1.13 0.62 0.63 0.57
Tnf 11.11 1.14 0.33 0.78 1.00
Traf2 1.00 1.00 1.00 0.75 1.00
Traf6 1.35 1.24 1.00 0.69 1.69
Nfkb1 4.00 0.76 0.62 1.00 1.13
Nfkb2 0.61 1.00 1.00 1.00 0.75
Rela 0.44 0.50 0.88 0.56 2.79
Relb 0.48 0.62 0.67 0.48 1.00
Ikkalpha 1.00 1.00 1.00 2.04 1.00
Ikkbetta 1.00 1.00 1.00 3.89 1.00
Ikbalpha 1.00 0.69 1.45 0.36 0.95
Il6 2.17 2.20 0.42 1.13 0.17
Shh 0.59 0.42 0.23 0.24 0.48
Fgf8 0.76 0.28 0.40 0.27 0.22
Fgf10 0.26 0.82 1.05 1.04 0.17
Fgfr2 1.00 0.83 0.83 1.00 1.00
Egf 1.00 10.00 12.50 50.00 100.00
Tgfalpha 0.38 10.56 12.81 23.33 27.59
Egfr 0.52 2.49 2.62 3.70 5.37
Erk1 1.00 1.00 2.14 0.41 2.24
Erk2 1.54 1.00 1.00 0.64 1.92
c-myc 1.96 1.04 1.21 0.37 1.64
Cyclind1 1.00 1.18 0.65 0.82 1.55
Cdk1 1.00 1.75 0.46 1.12 0.96
Pi3K 1.22 1.00 0.88 0.68 0.83
Akt 1.00 1.00 1.00 1.00 1.00
P53 0.70 0.64 0.88 0.71 1.71
Casp3 1.00 0.52 0.55 1.00 1.04
Stat3 1.00 1.00 1.40 0.53 2.01BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Discussion
In 1875, Charles Darwin presented a meticulous descrip-
tion of what we now know as X-linked Hypohydrotic
Ectodermal Dysplasia (XLHED): "I may give an analogous
case, communicated to me by Mr. W. Wedderburn of a
Hindoo [sic] family in Scinde, in which ten men, in the
course of four generations, were furnished, in both jaws
taken together, with only four small and weak incisor
teeth and with eight posterior molars. The men thus
affected have very little hair on their body, and become
bald early in life. They also suffer much during hot
weather from excessive dryness of their skin. It is remark-
able that no instance has occurred of a daughter being
affected...though they transmit the tendency to their sons;
and no case has occurred of a son transmitting it to his
sons" [62].
Patients with X-linked HED have since been shown to also
have SMG hypoplasia and variably reduced salivary secre-
tion [19-21,63]. The reduced saliva flow results in dryness
of the oral mucosa and predisposes XLHED patients to
dental caries and Candida albicans infections. Tabby
(EdaTa) is a mouse homologue of human XLHED, a model
of the human syndrome that displays near identity. Adult
EdaTa SMGs are hypoplastic with decreased granular con-
voluted ducts and acini, and there is a notable decrease in
immunodetectable mucin protein [14,15]. Prior studies
of in vitro SMG ontogeny suggested that Eda/Edar signal-
ing effects epithelial cell proliferation, lumen formation,
and histodifferentiation via the canonical NFκB pathway
[14]. Of great interest, although EdaTa results in a severely
diminished functional Eda ligand [3,4], hemizygosity
(males) and homozygosity (females) for the mutant allele
result in variable (mild to moderate) adult (mouse and
human) SMG hypoplasia, not aplasia [14,19-21,63].
The reproductive success of mus musculus, homo sapiens
and other thriving organisms is in no small measure due
to their robustness against perturbations, including gene
mutation. This robustness may be seen at all levels of bio-
logic organization from gene expression to terminal organ
differentiation and function. What might be the basis of
"robustian" rescue (partial or full) from perturbations?
Several recent lines of experimental evidence suggest that
cells, and their genetic regulatory networks, are dynami-
cally critical [64-68]. Such critical dynamical systems,
poised between dynamical order and chaos, maximize the
correlated behavior of variables in systems of many varia-
bles and maximize the diversity of what they can do as
they become larger [69]. In the present study, we sought
to detect and measure the degree of SMG developmental
robustness, and to elucidate its underlying genetic mech-
anism.
We began by clarifying the in vivo ontogeny of EdaTaasso-
ciated SMG pathology (Figs. 1, 2). From the Initial Bud
stage (E13) on, Tabby SMGs are smaller, exhibit fewer
branches and are developmentally delayed compared to
WT glands. This is consistent with the findings that in
immunodetected in the Late Pseudoglandular/Early Canalic-
ular stage (~E15) [14]. Of note, though Eda protein is
detectable through the Late Terminal Bud Stage (E18-19),
comparison of E18 Tabby and WT proacinar phenotypes
indicates that terminal differentiation (presumptive func-
tional maturation) is less affected by Eda loss-of-function.
Our prior in vitro study [14] clearly showed that control
glands express very little activated NFκB, but enhanced
Tabby SMGs exhibit a marked increase in Egf, Tgfα and Egfr  protein expression Figure 4
Tabby SMGs exhibit a marked increase in Egf, Tgfα 
and Egfr protein expression. A, B. Immunolocalization of 
Egf protein in E18 WT (A) and Tabby (B) SMGs. C, D. Immu-
nolocalization of Tgfα protein in E18 WT (C) and Tabby (D) 
SMGs. E, F. Immunolocalization of Egfr protein in E18 WT (E) 
and Tabby (F) SMGs. In WT glands, Egf, Tgfα and Egfr pro-
teins are localized to ductal and terminal bud epithelia. In 
Tabby glands, a substantial increase in immunodetectable Egf, 
Tgfα and Egfr proteins is seen. Bar, 20 μm.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Time course fits of the WT and Tabby experimental data for a subset of NFκB response genes: Edar (a, b); Fgf8 (c, d); Shh (e,  f), Egf (g, h) Figure 5
Time course fits of the WT and Tabby experimental data for a subset of NFκB response genes: Edar (a, b); Fgf8 
(c, d); Shh (e, f), Egf (g, h). The vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines 
labeled "WT data" are the quantitative RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are 
model simulated expected mRNA expression for wildtype SMGs. The lines labeled "TA data" are the quantitatively RT-PCR 
derived mRNA data in Tabby SMGs; the lines labeled "TA model" are model simulated expected mRNA expression for Tabby 
SMGs mice.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Eda/Edar signaling induces a very significant increase in
activated NFκB. What we did not show was whether or not
canonical NFκB activation was necessary or sufficient for
in vivo Eda/Edar signaling. We had our doubts because
Baltimore's group [70] had shown that p50-/- mice have
normal development, except for some postnatal (6 weeks)
defects in immune responses. Further, we investigated the
IkBα transgenic mouse created by Schmidt-Ullrich's group
[12,71] and the SMGs are normal (unpublished).
Branching morphogenesis is not a simple dichotomous
trait, one we mark present or absent. Rather, it is a com-
plex quantitative trait. Defining the interactions that occur
among the genes that underlie the process of branching is
essential to understanding its variability. When a gene
that is critical to this developmental process mutates, the
differentiating cells reprogram transcription via a cognate
genetic circuit, ultimately altering the expression of the
many genes beyond the mutated one. As such, the pheno-
type of a given genotype cannot be simply predicted by
the sum of its component single-locus effects, but must
take account of the almost certain epistasis in gene func-
tion [72]. The most efficient way of doing this is by sys-
tems analysis, correlation modeling for hypothesis
generation (e.g. [32,73,74]) and kinetic (mechanistic)
modeling for hypothesis testing [46,48,49,75,76].
The molecular pathology of embryonic Tabby (EdaTa)
SMGs is characterized by significantly (P < 0.01) downreg-
ulated Shh and Fgf8 gene expression, on the order of 50–
75% less than WT. Typically, this would be expected to be
associated with a severely hypoplastic to aplastic gland
[38,44], but this is not the case ([14]; Figs. 1, 2). One obvi-
ous explanation for this is the many-fold upregulation of
Egf/Tgfα/Egfr gene (Table 3) and protein (Fig. 4) expres-
sion. This dramatic robustness of the studied subcircuit
(Fig. 3; see Additional file 1) is largely due to degeneracy,
namely the ready availability of multiple parallel path-
ways at a key "choice point [34]. Mechanistic modeling
reveals that the primary linchpin of this degeneracy is not
canonical NFκB as previously supposed [14]; rather, we
provide extensive quantitative evidence that the Eda/Edar/
NFκB cascade plays a minor role, apparently neither nec-
essary nor sufficient for SMG development. We confirm
this with an in vitro strategy that demonstrates that loss of
NFκB function does not abrogate Eda-enhanced SMG
branching and differentiation (Figs. 7, 8). These outcomes
add support to the suggestion by Pispa et al [77] of an
important NFκB-independent pathway downstream of
Eda/Edar signaling in vivo.
The most parsimonious alternative explanation is a sec-
ond Eda-activated transcription factor ("TFx") that regu-
lates, alone or complexed with NFκB, the expression of all
five target genes: Shh, Fgf8, Egf, Tgfα, Egfr (Fig. 10). Our
initial in silico and in vivo investigations suggest that the
identity of TFx is C/EBPα, a regulator of cell proliferation
and differentiation [59]. There are likely other, as yet
unknown, TFs in the Eda/Edar pathway. Unmasking TFx
with certainty, and delineating its participation in tran-
scription factor complexes, could prove formidable [78];
Time course fits of the WT and Tabby experimental data for Nfkb1 gene expression Figure 6
Time course fits of the WT and Tabby experimental data for Nfkb1 gene expression. The vertical axis is the rela-
tive abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantitative RT-PCR derived 
mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA expression for wildtype 
SMGs. The lines labeled "TA data" are the quantitative RT-PCR derived mRNA data in Tabby SMGs; the lines labeled "TA 
model" are model simulated expected mRNA expression for Tabby SMGs mice.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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delineating the stochastic variation in cognate gene
expression more so [79].
The variable phenotypic expression of human hypohy-
drotic ectodermal dysplasia is considerable ([22,80]; Mel-
nick unpublished). This is particularly so for glandular
phenotypes (salivary, sweat, sebaceous, lacrimal, mam-
mary, and mucous). If branching epithelia use variations
of a canonical developmental program, the experimental
results presented here should be applicable to under-
standing the variable phenotypic expression of other
branching organs affected by Eda (EDA) mutation.
Conclusion
Our prior studies of in vitro SMG branching morphogene-
sis suggested that Eda/Edar signaling largely regulates
ontogeny through the canonical NFκB pathway [14]. The
present in vivo quantitative systems analyses indicate that
this conclusion must be amended. The need to do so is
inescapable because, for most NFκB-regulated genes, the
observed time course of gene expression is nearly
unchanged in Tabby mice as compared to wildtype mice
(see Additional file 2), as is NFκB itself (Fig. 6). Impor-
tantly, a subset of genes is dramatically differentially
expressed in the Tabby mouse (Edar, Fgf8, Shh, Egf, Tgfa,
Egfr) (Figs. 5, 9), strongly suggesting the existence of an
alternative Eda-mediated transcriptional pathway pivotal
for SMG branching morphogenesis (Fig. 10). Experimen-
tal and in silico investigations have identified C/EBPα as a
promising candidate (Fig. 11). Finally, it should be noted
that upregulation of the Egf/Tgfα/Egfr pathway appears to
mitigate the potentially severe abnormal phenotype pre-
dicted by the downregulation of Fgf8 and Shh. It has
recently been suggested by Harris et al. that the buffering
of the phenotypic outcome that is coincident with variant
Eda signaling could be a common mechanism that per-
mits viable and diverse phenotypes, including those we
would consider normal [81]. Our results support this
proposition.
Methods
Wildtype (WT) mice were either B6CBACaF1-AW-J/A (AW-
J) or B10.A/SgSn obtained from Jackson Laboratories (Bar
Harbor, ME) and bred as previously described (Jaskoll
and Melnick, 1999; Jaskoll et al., 2003); plug day = day 0
of gestation. Tabby breeding pairs [B6CBACA AW-J/A-
EdaTa/O/J (Ta/0) and B6CBACA AW-J/A-EdaTa/Y (Ta/Y)]
were obtained from Jackson Laboratories and kept by
breeding Ta/0 females to Ta/Y males. All embryos from
the cross were either Ta/0 or Ta/Ta females and Ta/Y males
and displayed the Tabby phenotype. The AW-J wildtype
SMGs were used for all comparisons with Tabby glands.
E13-19 Tabby and WT pregnant females and newborn
mice were sacrificed, SMGs were dissected in cold phos-
phate-buffered saline (PBS) and glands were collected for
morphological, immunolocalization or quantitative RT-
PCR. For histological analysis, SMGs were fixed for 4 hrs
in Carnoy's fixative at 4°C or overnight in 10% neutral
buffered formalin at room temperature, embedded in low
melting point paraplast, serially-sectioned at 8 μm and
stained with hematoxylin and eosin as previously
described [37]. For each embryonic day from gestation
day 13 to 18, 5–15 WT and Tabby SMGs were analyzed.
For  in vitro culture experiments, B10A/SnSg mice were
mated and pregnant females were sacrificed on day 14 of
gestation (E14) as previously described [14,44] Embry-
NFκB function is not essential for Eda signaling Figure 7
NFκB function is not essential for Eda signaling. A, B. 
E14 + 7 control SMG. C, D. E14 + 7 SMGs cultured in 100 
μg/ml SN50. E, F. E14 + 7 SMGs cultured in 250 ng/ml Eda-
A1 + 100 μg/ml SN50. A, C, E. Histological analysis. B, D, F. 
Immunolocalization of mucin protein. SN50 treatment (C, D) 
induces an abnormal glandular phenotype, characterized by a 
notable decrease in epithelial ducts and buds (b), dilated duc-
tal lumina (*) and a marked decrease in immunodetectable 
mucin protein compared to controls (compare C, D to A, B). 
EDA treatment of SN50-treated explants (E, F) rescues the 
SN50-induced abnormal phenotype and restores it toward 
that seen in controls (compare E, F to A, B). The Eda + 
SN50-treated glands exhibit a marked increase in epithelial 
ducts and buds, more normally-appearing lumina, and a 
marked increase in immunodetectable mucin protein com-
pared to glands treated with SN50 alone (compare E, F to C, 
D). Bar: A, C, E- 40 μm; B, D, F- 25 μm.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Comparative in vitro gene expression between E14 + 7 SMG explants with NFκB loss-of-function and those with Eda gain-of- function Figure 8
Comparative in vitro gene expression between E14 + 7 SMG explants with NFκB loss-of-function and those 
with Eda gain-of-function. A. Quantitative RT-PCR derived relative gene expression in SN50-treated (+SN50) and Eda-
treated (+Eda) explants compared to controls. B. Probabilistic Neural Network (PNN) analysis was used to determine the 
contribution of each gene to the discrimination between SN50-treated and Eda-treated phenotypes. PNN analyses identify the 
relative importance (0–1, with 0 being of no relative importance and 1 being relatively most important) of specific gene expres-
sion changes that distinguish between SN50-treated and Eda-treated phenotypes.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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onic SMGs were dissected under sterile conditions and in
vitro experiments conducted as outlined below.
All animal studies were conducted with the approval of
the appropriate committees regulating animal research.
An Animal Review Board and a Vivaria Advisory Commit-
tee review all applications to ensure ethical and humane
treatment.
Immunolocalization
E16-18 Tabby and WT (AW-J) glands were fixed for 4 hrs in
Carnoy's fixative at 4°C or overnight in 10% neutral buff-
ered formalin at room temperature, embedded in low
melting point paraplast, serially sectioned at 8 μm and
immunolocalization was conducted essentially as previ-
ously described [14,38,82] using the following affinity-
purified antibodies: polyclonal rabbit anti Muc10 [82,83],
polyclonal rabbit anti C/EBPα (sc-61; Santa Cruz Biotech-
nology), polyclonal rabbit anti Egfr (sc-03; Santa Cruz
Biotechnology), polyclonal goat anti Egf (sc-1343; Santa
Cruz Biotechnology) and monoclonal mouse anti Tgfα
(sc-36; Santa Cruz Biotechnology). In selected experi-
ments, nuclei were stained with 4,6-diamidino-2-phe-
nylindole (DAPI). For mucin protein localization, 3–4
WT and Tabby glands were analyzed for each embryonic
day and 3–6 explants per treatment group were analyzed.
For C/EBPα protein localization, 5 WT or Tabby glands
were analyzed and 3–5 explants per treatment group were
analyzed. For Egfr, Egf and Tgfα protein localization, 3–4
WT and Tabby glands were analyzed.
Time course fits of the WT and Tabby experimental data for Tgfa (a, b) and Egfr (c, d) gene expression Figure 9
Time course fits of the WT and Tabby experimental data for Tgfa (a, b) and Egfr (c, d) gene expression. The 
vertical axis is the relative abundance of mRNA, as presented in Tables 1 and 2. The lines labeled "WT data" are the quantita-
tive RT-PCR derived mRNA data in wildtype SMGs; the lines labeled "WT model" are model simulated expected mRNA 
expression for wildtype SMGs. The lines labeled "TA data" are the quantitative RT-PCR derived mRNA data in Tabby SMGs; 
the lines labeled "TA model" are model simulated expected mRNA expression for Tabby SMGs mice.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Quantitative RT-PCR
For analysis of gene expression, quantitative RT-PCR was
conducted as previously described [57]. WT and Tabby
SMGs were pooled (WT-E15-17: 6–20 SMGs/sample; E18-
NB: 2–4 SMGs/sample; Tabby-E16-17:15–20 SMGs/sam-
ple; E18-NB-4-6 SMGs/sample). For each embryonic day,
in each of WT and Tabby, we performed quantitative RT-
PCR on 9 or more independent samples. RNA was
extracted and 1 μg RNA was reverse transcribed into first
strand cDNA using ReactionReady™ First Strand cDNA
Synthesis Kit: C-01 for reverse transcription (Superarray
Biosciences, Frederick, MD). The primer sets used were
prevalidated to give single amplicons and purchased from
Superarray Biosciences: Eda (#PPM40603E); Edar
(#PPM32386A); Edaradd (PPM32128E); Fgf8
(#PPM02962C); Fgf10 (PPM0345A); Fgfr2
(PPM03706E); PI3k (PPM03469A); Akt (PPM03377A);
ERK1 (PPM03575A); ERK2 (PPM03571A); Stat3
(PPM04643E); Egf (PPM03703C); Tgfa (PPM03051A);
Egfr (PPM03714E); Ikbkb (PPM03198A); Nfkb1
(#PPM02930A); Nfkb2 (PPM03204A); Rela
(#PPM04224E); Relb (#PPM03202C); Tnf
(#PPM03113E); Traf2 (PPM03083E); Traf6
(PPM03082A); Il6 (#PPM03015A); p53 (#PPM02931A);
Shh (#PPM04516B); cyclin D1 (PPM02903A); Cdk1
(PPM02907A); Casp3 (PPM02922E); Myc (PPM02924A);
Alternative kinetic model incorporating unknown transcription factor (TFx) activation by Eda/Edar signaling Figure 10
Alternative kinetic model incorporating unknown transcription factor (TFx) activation by Eda/Edar signaling. 
This model is a diagram of the alternative hypothesis that is more consistent with the quantitative mRNA data for Eda/Edar sig-
naling than the hypothesis that NFκB1 serves as the main signaling pathway mediating Eda/Edar signaling. Black arrows repre-
sent processes (chemical reactions, transport, or binding). Rectangles represent states. A state is a molecule or complex in a 
physiologic place. The states are color coded as follows: Yellow is the unknown transcription factor TFx and its upstream acti-
vation signaling pathway; purple are the mRNA's; green are the promoters that are upregulated by TFx; red are the promoters 
that are downregulated by TFx. Places are represented by the background ivory or mauve bands of color and are labeled at the 
bottom of the diagram. Green and red dashed lines represent, respectively, positive or negative regulation of process by states. 
Processes with only starts or ends cross the boundary of the modeled system. This diagram was produced by ProcessDB soft-
ware http://www.integrativebioinformatics.com.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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Ikka (PPM03197A); Ikbkap (PPM37360A); Cebpa
(PPM04674A). Primers were used at concentration of 0.4
microM. The cycling parameters were 95°C, 15 min; 40
cycles of (95°C, 15 sec; 55°C, 30–40 sec and 72°C, 30
sec). Specificity of the reactions was determined by subse-
quent melting curve analysis. RT-PCRs of RNA (not
reverse transcribed) were used as negative controls.
GAPDH was used to control for equal cDNA inputs and
the levels of PCR product were expressed as a function of
GAPDH. The relative fold changes of gene expression
between the gene of interest and GAPDH, or between the
WT and Tabby, were calculated by the 2-ΔΔCTCT method.
Kinetic modeling and hypothesis testing
Data mining
Pathway and literature databases were mined for proc-
esses that interrelate a panel of pivotal genes in SMG
development (Fig. 3; Table 1). We extracted relevant inter-
actions and pathways from KEGG http://www.genome.jp,
OMIM http://www.ncbi.nlm.nih.gov/sites/ent
rez?db=omim, GeneCards http://www.genecards.org,
three models from the BioModels database http://
www.ebi.ac.uk/biomodels/, iHOP http://www.ihop-
net.org/UniPub/iHOP/, and the scientific literature
accessed through the PubMedCentral database http://
www.pubmedcentral.nih.gov/index.html. These data
were manually curated and entered into the ProcessDB
software http://www.integrativebioinformatics.com. In
some cases pathways were available in SBML http://
sbml.org/Main_Page format and these were programmat-
ically imported from the BioModels.net database into the
ProcessDB database for re-use. The resulting mechanistic
system diagram contains 138 states (a state is a molecule
or a complex in a physical place) in 5 cellular locations
(cytoplasm, nucleus, secretory pathway, plasma mem-
brane and extracellular fluid), and 217 processes (trans-
port, chemical reaction, or binding). It is too large to be
displayed legibly on a journal page, but is provided as a
scalable PDF file (see Additional file 1).
Kinetic analysis and modeling
Experimental mRNA expression data on the genes listed
in Table 1 were collected as described above and provided
mRNA data on E15, E16, E17, E18, E19, and newborn
(NB) for wild type (AW) embryos and on E16, E17, E18,
E19, and NB for Tabby embryos whose glands are uni-
formly and significantly smaller. For each gene analyzed
the data were normalized to the value obtained on E15 in
the wild type animals. The defining characteristic of the
Tabby mouse is an X-linked mutation that causes a major
reduction in Eda mRNA. The underlying goal of the mod-
eling work was to understand how this marked reduction
in Eda propagates through the signal transduction and
genetic networks to produce the observed temporal phe-
notypes for the measured panel of developmental genes.
A standard biophysical/bioengineering approach to
kinetic analysis of a complex system containing many
feedback and feedforward controls is to open the control
loops by use of forcing functions [84,85]. We took advan-
tage of the rich data set of measured mRNA time courses
by using them as forcing functions for protein synthesis in
the large-scale mechanistic kinetic model. This approach
C/EBPα protein immunolocalization in WT and Tabby glands  in vivo and in cultured SMGs Figure 11
C/EBPα protein immunolocalization in WT and 
Tabby glands in vivo and in cultured SMGs. A, B. In vivo 
distribution of C/EBPα protein in E17 WT (A) and Tabby (B) 
SMGs. C/EBPα protein is primarily localized in nuclei (arrow-
heads) of epithelial cells surrounding ductal and terminal bud 
lumina in E17 SMGs. There is a notable decrease in nuclear-
localized C/EBPα protein, as well as a marked increase in 
DAPI-stained nuclei, in Tabby glands (B) compared to WT 
glands (A). C, D. C/EBPα protein immunolocalization in cul-
tured control (C) and Eda-A1-treated (D) explants. Eda 
treatment (D) induces a marked increase in immunodectable 
and nuclear-localized (arrowheads) C/EBPα protein com-
pared to controls (compare D to C). Note that in controls 
glands (C), C/EBPα protein is found in the cytoplasm 
whereas the nuclei are labeled with DAPI alone (arrows). 
Inserts C, D. Higher magnifications showing cytoplasmic-
localized C/EBPα protein in controls (C) and nuclear-local-
ized C/EBPα protein in Eda-treated (D) SMGs. Bar, A-B: 20 
μm, C-D: 30 μm; C-D inserts: 10 μm.BMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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accelerates model development by propagating data-
determined (and presumably correct) time courses
through the network even before a consistent model has
been obtained. Because Tabby glands are too small at
ED15 to be practical for RT-PCR-based measurements,
some method of extrapolation back from ED16 to ED15
was required for the Tabby forcing functions. Two meth-
ods were possible: 1) assume the value at ED15 is equal to
the value at ED16 or 2) assume the slope determined by
values at ED16 and ED17 is the same as the slope between
ED15 and ED16. Choice 1 was seen as more conservative
and was implemented. Rate law parameters and initial
abundances were chosen throughout the protein network
to propagate the main features of each mRNA develop-
mental transient as faithfully as possible. Default rate
laws, based on mass action kinetics were created automat-
ically by ProcessDB for each process. This automatically
produces saturation behavior for processes limited by the
abundance of one or more reactants. Enzyme catalyzed
processes and processes activated or inhibited by other
states in the model were supplied with rate laws based on
classical rapid equilibrium enzyme kinetics [86].
Another useful modeling technique is, wherever feasible,
to analyze multiple experiments simultaneously using the
same mechanistic model. This could be implemented in
the ProcessDB software, even though the present experi-
ments are performed in two different mouse strains, by
adopting the working hypothesis that WT and Tabby mice
are identical except for the genetic defect in the Eda gene
of the Tabby mutant. In other words, all differences
between WT and Tabby developmental mRNA profiles are
assumed to be secondary to the difference in Eda expres-
sion. In some cases fitting the WT and Tabby data sets
required that states have different initial numerical values
at ED15. This was allowed because the cytokine environ-
ment of the salivary gland in early embryonic develop-
ment is undoubtedly different in the two strains. In all
cases, however, parameter values and rate laws were taken
as identical for the two strains. This is an extremely pow-
erful modeling constraint. It does not mean, of course,
that all unmeasured protein time courses are the same in
the WT and Tabby models. Each is driven by the measured
mRNA abundances so that known differences are propa-
gated through common rate laws with the objective of
testing the structure of the network – from cytokine pro-
duction and secretion to receptor binding to activation of
enzymes and transcription factors, to nuclear localization
and activation or inhibition of cognate genes.
Importantly, the use of mRNA forcing functions in no way
guarantees that the full model will simultaneously fit the
mRNA data that serve as forcing functions. This is because
the control of nuclear transcription factors is, in general,
multifactorial and mechanistically distant from synthesis
of the proteins involved. Consequently, it was possible to
test the mechanistic model's ability to account for the
experimental data by searching for transcription and
mRNA degradation parameters able to fit the WT and
Tabby data simultaneously. The full mechanistic model
file including all differential equations, ancillary algebraic
equations, rate laws and parameters is included in Addi-
tional files (see Additional file 1; Additional file 2; Addi-
tional file 3; Additional file 4; Additional file 5).
All differential equations and ancillary algebraic equa-
tions were formulated in ProcessDB and exported to the
Berkeley Madonna http://www.berkeleymadonna.com
solver for numerical integration and parameter optimiza-
tion using standard methods. Assembled pathway dia-
grams were treated as hypotheses and tested against the
WT and Tabby experimental data.
Transcription factor analysis
The mouse sequences of Fgf8, Shh, Eda, Tgfa, Egf, and Egfr
were analyzed for the presence of putative TF DNA bind-
ing sites that are common to all 6 genes. We began with
an unbiased search with AliBaba 2.1 http://www.genereg
ulation.com/pub/programs.html, the most specific tool
for predicting TF binding sites in an "anonymous" DNA
sequence using the TRANSFEC database of TFs. The out-
come was manually curated based upon mined pathway
and literature databases (see Kinetic Modeling/Data min-
ing above) and rank ordered. This analysis revealed SP1
and C/EBPα to be the most likely candidates. We then
analyzed both candidates with greater stringency using
MATCH 11.2 (proprietary; http://www.biobase-interna
tional.com) and P-MATCH 1.0 http://www.gene-regula
tion.com/pub/programs.html.
MATCH 11.2 is a weight matrix-based tool for searching
putative TF binding sites in DNA sequences [87]. MATCH
11.2 uses the matrix library collected in TRANSFAC 12.1
(proprietary; http://www.biobase-international.com).
Multiple sets of optimized matrix cut-off values are built
into the tool to provide a variety of search modes of differ-
ent stringency. The matrix similarity is a score (0–1) that
describes the quality of a match between matrix and an
arbitrary part of the input sequence. Analogously, the core
similarity score (0–1) denotes the quality of a match
between the core sequence of a matrix (the five most con-
served positions within a matrix) and a part of the input
sequence. A match has to contain the core sequence of a
matrix, i.e. the core sequence has to match with a score
higher than or equal to the core similarity cutoff. In addi-
tion, only those matches which score higher than or equal
to the matrix similarity threshold appear in the output.
Cut-offs were chosen to minimize false positive and falseBMC Developmental Biology 2009, 9:32 http://www.biomedcentral.com/1471-213X/9/32
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negative outcomes. Of the two candidate TFs revealed by
AliBaba 2.1, only C/EBPα survived the more rigorous
analysis.
This outcome was confirmed using P-MATCH 1.0. P-
MATCH combines weight-matrix and pattern matching
analytical strategies, thus providing higher accuracy of rec-
ognition than either method alone [88]. P-MATCH 1.0
uses the library of mononucleotide weight matrices from
TRANSFAC 6.0 (public) along with the site assignments
associated with the matrices. Comparisons with MATCH,
show that P-MATCH generally provides enhanced recog-
nition accuracy vis-à-vis lower false negative errors (i.e.
high sensitivity).
EDA-A1 supplementation in vitro
To determine the optimal concentration of exogenous sol-
uble human recombinant EDA-A1 that induces a signifi-
cant increase in SMG branching and morphogenesis, we
conducted a dose response study. This dose response
study was conducted because the EDA-A1 recombinant
set (EDA-A1 + enhancer molecule) (Alexis Biochemicals,
Axxora, LLC, San Diego, CA) in the present set of experi-
ments was different from the EDA-A1 peptide employed
in our previous study [14]. A stock solution of 1 Φg/ml
EDA-A1 (10 Φl EDA-A1 + 5 Φl Enhancer + 985 Φl BGJb
containing 1% BSA) was made following the manufac-
turer's protocol and then diluted to 100, 250 and 500 ng/
ml. Paired E14 SMG primordia were cultured for 2 days
(E14 + 2) and 5–7 days in the presence or absence of 100,
250 and 500 ng/ml EDA-A1. For E14 + 2 explants,
Spooner branch ratios (epithelial bud number on day 2/
bud number on day 0) were calculated for each explant,
comparisons made between right and left glands (treated
and control) from each embryo and mean Spooner ratios
determined as previously described [14,38,44]. The data
were arcsin transformed and compared by paired t-test for
all embryos studied [89]. Since branching morphogenesis
is too complex to count in E14 explants cultured 5–7 days,
the morphology of these explants were analyzed by rou-
tine hematoxylin and eosin histology; 4–6 explants per
dose were analyzed for each day of culture. We deter-
mined the optimal dose to be 250 ng/ml EDA-A1 and this
concentration was used in all subsequent experiments.
SN50 inhibition of canonical NF6B nuclear translocation
The cell permeable peptide SN50 (Biomol Research, Ply-
mouth Meeting, PA) has been shown to inhibit transloca-
tion of the canonical NFκB1/RelA pathway into the
nucleus [32,56,90]. To determine the effect of SN50 on
E14 SMG morphogenesis, paired E14 SMG primordia
were cultured for 2 days or 5–7 days in the presence or
absence of 100 μg/ml SN50. This concentration was pre-
viously shown in our laboratory to be the optimal inhibi-
tor of NFκB1/RelA translocation and interrupts SMG
morphogenesis [32,57]. The morphology of these
explants was analyzed by routine hematoxylin and eosin
histology; 4–6 explants per treatment group were ana-
lyzed.
In vitro rescue experiments
To determine if exogenous EDA-A1 rescues SN50-induced
abnormal phenotypes, E14 SMGs were cultured for 7 days
in the presence of 250 ng/ml EDA-A1, 100 μg/ml SN50 or
250 ng/ml EDA-A1 + 100 μg/ml SN50; control SMGs con-
sisted of explants cultured in control medium. E14 + 7
explants were collected for histological analysis or quanti-
tative RT-PCR as described above. The morphology of
these explants was analyzed by routine hematoxylin and
eosin histology; 20–25 explants per treatment group were
analyzed. For RT-PCR, 9 independent samples per treat-
ment of pooled glands (20–25 SMGs/sample/group) were
analyzed.
Probabilistic neural network (PNN) analysis
We used PNN analyses to determine the contribution of
each individual gene to the discrimination between exper-
imental groups with 100% sensitivity and specificity. As
such, PNN analyses identify the relative importance (0–1,
with 0 being of no relative importance and 1 being rela-
tively most important) of specific gene expression changes
that discriminate between phenotypes. It is the contextual
change in expression, not the direction of change that is
important in defining the molecular phenotype. The
foundational algorithm we used is based upon the work
of Specht and colleagues [91-93]. The proprietary software
designed by Ward Systems Group (Frederick, MD) formu-
lates Specht's procedure around a genetic algorithm [94].
A genetic algorithm is a computational method modeled
on biologic evolutionary processes that can be used to
find the optimum solution to a problem that may have
many solutions [95]. These algorithms have been found
to be very powerful in solving optimization problems that
appear to be difficult or unsolvable by traditional meth-
ods. They use a minimum of information about the prob-
lem and they only require a quantitative estimation of the
quality of a possible solution. This makes genetic algo-
rithms easy to use and applicable to most optimization
problems.
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abundance of mRNA, as presented in Tables 1 and 2. The lines labeled 
"WT data" are the quantitative RT-PCR derived mRNA data in wildtype 
SMGs; the lines labeled "WT model" are model simulated expected 
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quantitative RT-PCR derived mRNA data in Tabby SMGs; the lines 
labeled "TA model" are model simulated expected mRNA expression for 
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Corresponding equations of the computational model. Text file display-
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